Otezla® (apremilast) Psoriasis Clinical Trial
Do you have Psoriasis?
OptiSkin is looking for healthy volunteers to join our paid clinical trials. Eligible volunteers with psoriasis will receive oral medication. Volunteer today and help pave the next generation of eczema treatments.
Duration
Study length is 28-32 weeks after enrollment. There are a total of 4 in-person visits required. Participants will be compensated for time and travel.
Study Specifics
For adult patients 18+ who have been diagnosed with severe psoriasis. Patients must be treated with Otezla® (apremilast) therapy once enrolled.
Eligibility
To participate, you MUST have:
- Severe Psoriasis
You will NOT be eligible if:
- you have received Otezla® (apremilast) in the past
- you are currently enrolled in another clinical trial
Additional inclusion/exclusion criteria will apply.